Skip to main content
CTOS 2025 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Mandy Ballinger, BSc, PhD, MGenCouns (she/her/hers)

Deputy Director
Centre for Molecular Oncology
Sydney, New South Wales, Australia

Associate Professor Mandy Ballinger is Deputy Director of the University of New South Wales Centre for Molecular Oncology and Head of Cohorts for Omico. She oversees a program of work focused on defining heritable cancer risk in sarcomas and other early on-set cancers. A/Prof Ballinger was key to establishing the International Sarcoma Kindred Study in 2009 and was first author on leading papers investigating sarcoma predisposition. She leads the Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+), the Australian whole body MRI study for individuals with multi-organ cancer prone syndromes. A/Prof Ballinger’s work in Li Fraumeni syndrome has impacted clinical practice internationally and has led to an Australian Medicare item number for whole body scans for early cancer detection. A/Prof Ballinger continues to use research cohorts as vehicles for intervention to impact clinical practice and improve patient outcomes.

Presentation(s):